121 related articles for article (PubMed ID: 9075266)
21. Action of the cholecystokinin antagonist L364,718 on gastric emptying in the rat.
Green T; Dimaline R; Peikin S; Dockray GJ
Am J Physiol; 1988 Nov; 255(5 Pt 1):G685-9. PubMed ID: 3056036
[TBL] [Abstract][Full Text] [Related]
22. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
[TBL] [Abstract][Full Text] [Related]
23. Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in nucleus accumbens of the rat via the CCK-B receptor.
Pu SF; Zhuang HX; Han JS
Brain Res; 1994 Sep; 657(1-2):159-64. PubMed ID: 7820614
[TBL] [Abstract][Full Text] [Related]
24. Electrophysiological and autoradiographical evidence for cholecystokinin A receptors on rat isolated nodose ganglia.
Widdop RE; Krstew E; Mercer LD; Carlberg M; Beart PM; Jarrott B
J Auton Nerv Syst; 1994; 46(1-2):65-73. PubMed ID: 8120343
[TBL] [Abstract][Full Text] [Related]
25. Peripheral cholecystokinin A and cholecystokinin B receptors mediate stimulation of gastric pepsinogen and acid secretion following intracerebroventricular injection of cholecystokinin-8-sulphate.
Blandizzi C; Lazzeri G; Carignani D; Colucci R; Baschiera F; Tognetti M; Placanica G; Del Tacca M
Ital J Gastroenterol Hepatol; 1999; 31(6):440-8. PubMed ID: 10575559
[TBL] [Abstract][Full Text] [Related]
26. A CCK(A)-receptor antagonist administered to the neonate alters mother-infant interactions in the rat.
Weller A; Dubson L
Pharmacol Biochem Behav; 1998 Apr; 59(4):843-51. PubMed ID: 9586840
[TBL] [Abstract][Full Text] [Related]
27. A possible interaction between serotonin and cholecystokinin-8 in the ileo-colonic motor responses to feeding in rats.
Benouali-Pellissier S; Roger T; Roche M
Scand J Gastroenterol; 1994 Feb; 29(2):138-43. PubMed ID: 8171281
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a gastrin-type receptor on rabbit gastric parietal cells using L365,260 and L364,718.
Roche S; Bali JP; Galleyrand JC; Magous R
Am J Physiol; 1991 Feb; 260(2 Pt 1):G182-8. PubMed ID: 1996638
[TBL] [Abstract][Full Text] [Related]
29. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP
J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021
[TBL] [Abstract][Full Text] [Related]
30. Effects of selective cholecystokinin antagonists L364,718 and L365,260 on food intake in rats.
Reidelberger RD; Varga G; Solomon TE
Peptides; 1991; 12(6):1215-21. PubMed ID: 1815209
[TBL] [Abstract][Full Text] [Related]
31. Cholecystokinin (CCK) regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors in sheep.
Zavros Y; Shulkes A
J Physiol; 1997 Dec; 505 ( Pt 3)(Pt 3):811-21. PubMed ID: 9457654
[TBL] [Abstract][Full Text] [Related]
32. Cholecystokinin octapeptide inhibits carbohydrate but not protein intake.
Mamoun AH; Bergström J; Södersten P
Am J Physiol; 1997 Sep; 273(3 Pt 2):R972-80. PubMed ID: 9321876
[TBL] [Abstract][Full Text] [Related]
33. CCKA and CCKB receptor subtypes both mediate the effects of CCK-8 on myenteric neurons in the guinea-pig ileum.
Schutte IW; Akkermans LM; Kroese AB
J Auton Nerv Syst; 1997 Dec; 67(1-2):51-9. PubMed ID: 9470144
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
Louie DS; Liang JP; Owyang C
Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
[TBL] [Abstract][Full Text] [Related]
35. Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin.
Altar CA; Boyar WC
Brain Res; 1989 Apr; 483(2):321-6. PubMed ID: 2706523
[TBL] [Abstract][Full Text] [Related]
36. High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats.
Li Y; Hao Y; Owyang C
Am J Physiol; 1997 Sep; 273(3 Pt 1):G679-85. PubMed ID: 9316472
[TBL] [Abstract][Full Text] [Related]
37. Lack of interaction between devazepide and 8-OH-DPAT-induced hyperphagia in the rat.
Francis J; Dourish CT; Cooper SJ
Physiol Behav; 1996 Nov; 60(5):1337-40. PubMed ID: 8916191
[TBL] [Abstract][Full Text] [Related]
38. [Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in amygdala of the rat].
Pu SF; Han JS
Sheng Li Xue Bao; 1993 Oct; 45(5):470-8. PubMed ID: 8146670
[TBL] [Abstract][Full Text] [Related]
39. L364,718 antagonizes the cholecystokinin-induced suppression of locomotor activity.
Soar J; Hewson G; Leighton GE; Hill RG; Hughes J
Pharmacol Biochem Behav; 1989 Jul; 33(3):637-40. PubMed ID: 2587606
[TBL] [Abstract][Full Text] [Related]
40. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
Millington WR; Mueller GP; Lavigne GJ
J Pharmacol Exp Ther; 1992 May; 261(2):454-61. PubMed ID: 1578360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]